Neuromodulation - Boston Scientific supports fellows and grant-funded work focused on technologies physicians use in the clinical treatment of chronic pain and neurological conditions.
The fellowship cycle changed from 2026–2027 to 2027–2028, with the submission deadline moving from January 30, 2026 to February 5, 2027. Applications open November 30, 2026 instead of December 3, 2025; review moves from May 22, 2026 to a tentative May 21, 2027.
Funder: Boston Scientific
Due Dates: November 30, 2026 (Fellowship applications open) | December 18, 2026 (Standard) | January 22, 2027 (Standard) | February 5, 2027 (2027–2028 Fellowships) | February 19, 2027 (Standard) | March 19, 2027 (Standard) | April 30, 2027 (Standard) | May 21, 2027 (Standard) | June 18, 2027 (Standard) | July 23, 2027 (Standard) | August 20, 2027 (Standard) | September 24, 2027 (Standard) | October 22, 2027 (Standard) | November 19, 2027 (Standard) | December 17, 2027 (Standard)
Funding Amounts:
Summary: Boston Scientific offers neuromodulation grants, including fellowships, in the clinical context of treating chronic pain and neurological conditions.
Boston Scientific’s Neuromodulation grant program provides support in a clinical area focused on technologies physicians use to treat chronic pain and neurological conditions. The program is administered through the Boston Scientific Corporation Neuromodulation Grant Committee, with a grant coordinator based in Valencia, California.
The program includes a dedicated fellowship application cycle alongside a standard grant submission and review schedule. The published fellowship cycle covers 2027–2028, while the standard schedule provides recurring submission deadlines through December 2027. Boston Scientific’s Core Businesses page provides further information about the medical conditions treated by its Neuromodulation business and the solutions it offers.